12:00 AM
 | 
Aug 07, 2000
 |  BC Week In Review  |  Company News  |  Deals

MethylGene, MGI deal

MOGN obtained North American rights from MethylGene to develop MG98 and other small molecule inhibitors of DNA methyltransferase to...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >